Krystal Biotech, Inc. (KRYS)
288.31
-0.68
(-0.24%)
USD |
NASDAQ |
May 07, 10:43
Krystal Biotech Free Cash Flow : 237.38M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Scholar Rock Holding Corp. | -300.64M |
| Stoke Therapeutics, Inc. | 44.92M |
| Moderna, Inc. | -1.603B |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| TG Therapeutics, Inc. | -24.99M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 80.38M |
| Cash from Investing (Quarterly) | -63.58M |
| Cash from Financing (Quarterly) | -10.46M |
| Free Cash Flow Per Share (Quarterly) | 2.401 |
| Free Cash Flow to Equity (Quarterly) | 73.46M |
| Free Cash Flow to Firm (Quarterly) | 73.23M |
| Free Cash Flow Yield | 2.74% |